2013 Ophthalmology Innovation Summit Innovator Awards

William J. Link PhD, Managing Director for Versant Ventures, announces the winners of the 2013 OIS Innovator Award. Describing the caliber and achievement that merits this award, Bill recognizes Thomas Burns, President & CEO for Glaukos, and Richard Hill MD, Co-Founder for Glaukos, for their high impact ophthalmic innovations that have successfully improved the lives…

Read More

AMAO76 Alleviates the Pressure for Amakem Therapeutics

Jack Elands, CEO for Amakem, talks about his company’s focus on a localized drug action platform, and details the company’s feature glaucoma product to lower intraocular pressure designated, AMAO76 rokinase inhibitor. Presenter: Jack Elands Dr. Jack Elands has been the CEO of Amakem since its inception. Before, Jack was CBO of Silicos, an informatics based…

Read More

Aerie Advances to the Next Round in Glaucoma Treatment

Vicente Anido Jr. PhD, Chairman & CEO for Aerie Pharmaceuticals, provides the attendees of the 5th Annual Ophthalmology Innovation Summit with an overview of Aeries rapid changes throughout the past year. Aerie focuses on the treatment of Glaucoma and has two major products, AR-1324 and Latanapross. Having just completed their initial Public Offering, Aerie can…

Read More

Large Device Companies Eyeing Opportunities in Ophthalmic Space

NEW ORLEANS — The oft-repeated Cajun expression in this fun loving town, ”laissez les bon temps roulez,” translated as let the good times roll may be an accurate way of summarizing the upbeat mood at this year’s annual meeting of the American Academy of Ophthalmology (AAO; San Francisco). The AAO is by far the largest…

Read More

FDA Focus on More Efficient Processing Yields Faster Decisions

SAN FRANCISCO — The U.S. Food and Drug Administration has been criticized for its ponderous movement of potential drugs and medical devices through the approval process. Recognizing this criticism, and following implementation of the Medical Devices User Fee and Modernization Act of 2002 and subsequent internal reevaluations and reorganizations, the FDA approval process for innovative…

Read More

OIS@ASCRS 2013 Executive Summary – Eye on Innovation

The Second Annual OIS@ASCRS – Ophthalmology Innovation Summit at the American Society of Cataract and Refractive Surgery was held in San Francisco on April 18, 2013. The conference attracted 325 attendees from 29 US states and 21 countries. The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse…

Read More

FDA – Medical Device Pathway: Tough Questions, Clear Answers

Tackling some of the most difficult topics surrounding medical devices and approval with the FDA, Bill Link, Managing Director for Versant Ventures leads Malvina Eydelman, Director for the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, through an interview that brings her highly diverse and expert knowledge to the forefront for attendees of…

Read More